Research Article

Percutaneous Lauromacrogol Foam Sclerotherapy for the Treatment of Acute Airway Compression Caused by Lymphatic Malformations in Infants

Figure 1

17-month-old female with lymphatic malformations (LMs) in the left cervical region that suddenly expanded over a 10-day period. The heart rate decreased and she underwent endotracheal intubation for dyspnea. (a)-(b) Computed tomography (CT) image revealing multilocular LMs (58 × 37 × 50 mm). The airway is obviously compressed and shifted. (c) Imaging for positioning. (d)-(e) Multiple points were percutaneously punctured and 25 mL of fluid was aspirated. (f) Preparation for the lauromacrogol foam injection. (g) Injection of the lauromacrogol foam. (h) The local compression bandage applied after treatment. (i) At the 1-month follow-up appointment, the mass was obviously shrunken. Three additional treatment sessions were then completed. (j) After 6 months, the mass disappeared. (k)-(l) The CT scan showing that the cyst was obviously decreased and the residual cystic cavity showed no lymph left.
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)
(k)
(l)